Evolus (EOLS)
(Delayed Data from NSDQ)
$9.15 USD
+0.23 (2.58%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $9.15 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Evolus, Inc. has a market cap of $575.12M, which represents its share price of $8.92 multiplied by its outstanding shares number of 64.48M. As a small-cap company, EOLS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
EOLS 9.15 +0.23(2.58%)
Will EOLS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EOLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EOLS
Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for
Earnings Preview: Evolus, Inc. (EOLS) Q2 Earnings Expected to Decline
EOLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Evolus, Inc. (EOLS) Reports Q1 Loss, Misses Revenue Estimates
SNDL Inc. (SNDL) Reports Q1 Loss, Misses Revenue Estimates
Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know
Other News for EOLS
Evolus to Report Second Quarter Financial Results on August 5, 2025 | EOLS Stock News
Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News
EOLS Partners with Symatese for Nuceiva Distribution in France | EOLS Stock News